Beijing SL Pharmaceutical Co Ltd (002038) — Capital Reinvestment Ratio
Beijing SL Pharmaceutical Co Ltd (002038) has a Capital Reinvestment Ratio of 0.17x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥66.55 Million) in capital expenditures (CN¥11.35 Million). See Beijing SL Pharmaceutical Co Ltd (002038) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Beijing SL Pharmaceutical Co Ltd Capital Reinvestment Ratio (2003–2025)
This chart tracks Beijing SL Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 23 annual periods. Check total reinvestment intensity of Beijing SL Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Beijing SL Pharmaceutical Co Ltd (2003–2025)
Year-by-year Capital Reinvestment Ratio for Beijing SL Pharmaceutical Co Ltd from 2003 to 2025. For live market cap and broader valuation context, see 002038 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.75x | CN¥257.66 Million | CN¥192.97 Million | ▼ -51.4% |
| 2024 | 1.54x | CN¥225.49 Million | CN¥347.38 Million | ▲ +224.7% |
| 2023 | 0.47x | CN¥460.20 Million | CN¥218.36 Million | ▲ +13.1% |
| 2022 | 0.42x | CN¥389.82 Million | CN¥163.49 Million | ▼ -17.7% |
| 2021 | 0.51x | CN¥464.63 Million | CN¥236.91 Million | ▼ -17.2% |
| 2020 | 0.62x | CN¥415.84 Million | CN¥255.95 Million | ▲ +50.2% |
| 2019 | 0.41x | CN¥665.83 Million | CN¥272.78 Million | ▼ -12.6% |
| 2018 | 0.47x | CN¥485.17 Million | CN¥227.37 Million | ▼ -22.3% |
| 2017 | 0.60x | CN¥380.72 Million | CN¥229.65 Million | ▲ +45.8% |
| 2016 | 0.41x | CN¥396.86 Million | CN¥164.21 Million | ▲ +61.1% |
| 2015 | 0.26x | CN¥504.87 Million | CN¥129.68 Million | ▼ -20.9% |
| 2014 | 0.32x | CN¥465.00 Million | CN¥151.01 Million | ▲ +3.1% |
| 2013 | 0.32x | CN¥347.41 Million | CN¥109.48 Million | ▼ -49.3% |
| 2012 | 0.62x | CN¥398.60 Million | CN¥247.89 Million | ▲ +94.6% |
| 2011 | 0.32x | CN¥228.59 Million | CN¥73.05 Million | ▲ +76.8% |
| 2010 | 0.18x | CN¥238.13 Million | CN¥43.04 Million | ▲ +3.5% |
| 2009 | 0.17x | CN¥174.41 Million | CN¥30.46 Million | ▲ +43.7% |
| 2008 | 0.12x | CN¥194.32 Million | CN¥23.61 Million | ▼ -59.7% |
| 2007 | 0.30x | CN¥88.36 Million | CN¥26.61 Million | ▼ -73.3% |
| 2006 | 1.13x | CN¥57.55 Million | CN¥64.95 Million | ▼ -34.0% |
| 2005 | 1.71x | CN¥47.48 Million | CN¥81.24 Million | ▲ +201.6% |
| 2004 | 0.57x | CN¥31.26 Million | CN¥17.73 Million | ▲ +5.5% |
| 2003 | 0.54x | CN¥30.55 Million | CN¥16.43 Million | — |